A high-quality insurance brokerage franchise with excellent cash conversion and an unbroken four-quarter earnings beat streak is navigating a confirmed near-term price downtrend with heavy revenue concentration in a single business segment—warranting a patient, watch-and-wait stance while the technical setup stabilizes.
Thesis pillars
- Revenue Concentrated In Single Segment↓Deteriorating
- Quality Franchise Exceptional Cash Conversion→Stable
- Confirmed Near Term Price Downtrend↑Improving
- +1 more pillar — see the Why tab for full reasoning
Marsh (MRSH) Stock Analysis
Financial Services · Insurance Brokers
Hold if already holding. Not a fresh buy at $185.74, but acceptable to hold if already in. Reasons: Concentration risk — Product: Risk and Insurance Services (64.0%); Concentration risk — Product: Marsh Risk (54.0%).
Marsh & McLennan Companies generated $27 billion in annual revenue in 2025 through two segments — Risk and Insurance Services (approximately 64% of revenue, via Marsh Risk and Guy Carpenter) and Consulting (approximately 36%, via Mercer and Marsh Management Consulting) —... Read more
Hold if already holding. Not a fresh buy at $185.74, but acceptable to hold if already in. Reasons: Concentration risk — Product: Risk and Insurance Services (64.0%); Concentration risk — Product: Marsh Risk (54.0%). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 5.5/10, moderate confidence.
Passes 6/9 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 40d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
Recent developments
updated 2026-09-05Recent Developments — Marsh
Latest news
- NEWS Marsh & McLennan (MRSH) Reinvents Operations with AI Productivity Push - Yahoo Finance — Yahoo Finance positive
- NEWS Will Higher Operating Expenses Play Spoilsport for Marsh Q2 Earnings? - TradingView — TradingView neutral
- NEWS Marsh: Repurchased About 4.5 Million Shares of Stock for $750 Million in 2Q >MRSH - Moomoo — Moomoo positive
- NEWS Marsh (NYSE:MRSH) Exceeds Q2 CY2026 Expectations - StockStory — StockStory positive
- NEWS Marsh (NYSE:MRSH) Exceeds Q2 CY2026 Expectations - TradingView — TradingView positive
Generated 2026-09-05T21:56:56Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHProductRisk and Insurance Services64%10-K Item 1: 'RISK AND INSURANCE SERVICES ... accounted for approximately 64% of the Company's total revenue in 2025'
- HIGHProductMarsh Risk54%10-K Item 1: 'MARSH RISK ... generated approximately 54% of the Company's total revenue in 2025'
Material Events(8-K, last 90d)
- 2026-06-04Item 1.01MEDIUMMarsh entered a new Amended and Restated 5-year $4.25 billion multi-currency unsecured revolving credit facility with Citibank, N.A. as administrative agent, maturing June 2031. Interest at Term SOFR plus a fixed margin varying with Marsh's credit ratings.SEC filing →
- 2026-06-04Item 1.02MEDIUMPrior revolving credit facility terminated in connection with entry into Amended and Restated 5-year $4.25 billion credit agreement with Citibank, N.A. dated June 2, 2026. No reason cited beyond routine refinancing and extension.SEC filing →
- 2026-04-14Item 5.02LOWMark McGivney appointed EVP, Chief Operating Officer & CFO effective April 15, 2026, expanding his role from SVP and CFO (held since January 2016). Annual base salary set at $1,250,000. McGivney retains CFO title; no separate CFO successor named.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $185.74, but acceptable to hold if already in. Reasons: Concentration risk — Product: Risk and Insurance Services (64.0%); Concentration risk — Product: Marsh Risk (54.0%). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Target $186.39 (+0.3%), stop $178.61 (−4.0%), A.R:R 0.1:1. Score 5.5/10, moderate confidence.
Take-profit target: $186.39 (+0.3% upside). Target $186.39 (+0.3%), stop $178.61 (−4.0%), A.R:R 0.1:1. Stop-loss: $178.61.
Concentration risk — Product: Risk and Insurance Services (64.0%); Concentration risk — Product: Marsh Risk (54.0%); Analyst target reached - limited upside remaining.
Marsh trades at a P/E of 23.0 (forward 16.3). TrendMatrix value score: 5.8/10. Verdict: Hold.
31 analysts cover MRSH with a consensus score of 3.5/5. Average price target: $207.
What does Marsh do?Marsh & McLennan Companies generated $27 billion in annual revenue in 2025 through two segments — Risk and Insurance...
Marsh & McLennan Companies generated $27 billion in annual revenue in 2025 through two segments — Risk and Insurance Services (approximately 64% of revenue, via Marsh Risk and Guy Carpenter) and Consulting (approximately 36%, via Mercer and Marsh Management Consulting) — advising clients in 130 countries with over 95,000 employees. Revenue comes from insurance and reinsurance broking commissions, client fees for consulting and investment management, and fiduciary interest income on premiums held for clients.